SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-218740
Filing Date
2022-08-11
Accepted
2022-08-11 17:27:14
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d386684d10q.htm   iXBRL 10-Q 638429
2 EX-31.1 d386684dex311.htm EX-31.1 12008
3 EX-31.2 d386684dex312.htm EX-31.2 11186
4 EX-32.1 d386684dex321.htm EX-32.1 4425
5 EX-32.2 d386684dex322.htm EX-32.2 5259
  Complete submission text file 0001193125-22-218740.txt   3755906

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA flac-20220630.xsd EX-101.SCH 35272
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flac-20220630_cal.xml EX-101.CAL 16492
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flac-20220630_def.xml EX-101.DEF 190282
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flac-20220630_lab.xml EX-101.LAB 232442
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flac-20220630_pre.xml EX-101.PRE 231056
46 EXTRACTED XBRL INSTANCE DOCUMENT d386684d10q_htm.xml XML 543026
Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Filer) CIK: 0001828326 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39765 | Film No.: 221157031
SIC: 6770 Blank Checks